Epidermal growth factor: receptor and ligand expression in human breast cancer.
The epidermal growth factor (EGF) gene is expressed by most human breast cancer cell lines as well as 83% of human breast cancers in vivo. Furthermore, EGF mRNA is detectable in normal human breast tissue. These data suggest that EGF may have a functional role in both normal and neoplastic human breast tissue. Expression of EGF was generally highest in steroid receptor positive human breast tumor biopsies and cell lines. EGF expression was increased by progestins in T-47D and ZR 75 human breast cancer cells. Furthermore, progestins specifically increased the level of TGF-alpha and EGF-receptor mRNA in T-47D cells. Under these same conditions progestins inhibit growth of the cells. Regulation of expression of EGF, TGF-alpha and the EGF-receptor is unlikely to be directly related to the mechanism of progestin induced growth inhibition in T47-D cells. T-47D-5 cells are more sensitive than T-47D cells to progestin and antiestrogen induced growth inhibition. T-47D-5 cells do not express EGF and contain very low levels of TGF-alpha mRNA. The higher level of EGF and TGF-alpha expression in T-47D cells may be one mechanism by which these cells decrease their sensitivity to growth inhibition by progestins and antiestrogens.
Murphy
L C
LC
Department of Biochemistry and Molecular Biology, University of Manitoba, Winnipeg, Canada.
Dotzlaw
H
H
Wong
M S
MS
Miller
T
T
Mrockowski
B
B
Gong
Y
Y
Murphy
L J
LJ
D001943:Breast Neoplasms / Q000235:genetics* / Q000648:ultrastructure; D004815:Epidermal Growth Factor / Q000235:genetics* / Q000502:physiology; D066246:ErbB Receptors / Q000235:genetics* / Q000502:physiology; D005260:Female; D015972:Gene Expression Regulation, Neoplastic / Q000502:physiology*; D006801:Humans
D004815:Epidermal Growth Factor; D066246:ErbB Receptors